Company Filing History:
Years Active: 2017-2025
Title: Ilan Ifergan: Innovator in Infection Diagnostics
Introduction
Ilan Ifergan is a notable inventor based in Haifa, Israel. He has made significant contributions to the field of medical diagnostics, particularly in the area of infection detection. With a total of 5 patents to his name, Ifergan is recognized for his innovative approaches to improving patient care.
Latest Patents
Ifergan's latest patents focus on the development of diagnostic kits that can distinguish between bacterial and viral infections. One of his inventions includes a kit that utilizes antibodies specifically designed to bind to TNF-related apoptosis-inducing ligand (TRAIL) protein and Procalcitonin (PCT) protein. This innovation addresses the critical issue of antibiotic misuse, which occurs when antibiotics are prescribed for non-bacterial infections. It is estimated that 40-70% of antibiotic courses worldwide are mis-prescribed, leading to significant financial and health consequences. Ifergan's work aims to provide reliable diagnostics that assist physicians in making accurate treatment decisions, particularly at the point-of-care where most antibiotics are prescribed.
Career Highlights
Ilan Ifergan is currently associated with Memed Diagnostics Ltd., a company dedicated to advancing diagnostic technologies. His work has been instrumental in developing methods that utilize biomarkers for the rapid detection of infection sources. This innovation is crucial in combating the rise of antibiotic-resistant bacteria, which poses a major threat to public health.
Collaborations
Ifergan collaborates with talented professionals in his field, including Kfir Oved and Eran Eden. Their combined expertise contributes to the ongoing development of innovative diagnostic solutions.
Conclusion
Ilan Ifergan's contributions to infection diagnostics highlight the importance of innovation in healthcare. His patents and ongoing work at Memed Diagnostics Ltd. are paving the way for more effective and responsible antibiotic use. Through his efforts, Ifergan is making a significant impact on public health and patient care.